These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10717235)

  • 1. Translocation and coamplification of loci from chromosome arms 8p and 11q in the MDA-MB-175 mammary carcinoma cell line.
    Adélaïde J; Chaffanet M; Mozziconacci MJ; Popovici C; Conte N; Fernandez F; Sobol H; Jacquemier J; Pébusque M; Ron D; Lafage-Pochitaloff M; Birnbaum D
    Int J Oncol; 2000 Apr; 16(4):683-8. PubMed ID: 10717235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
    Bautista S; Theillet C
    Genes Chromosomes Cancer; 1998 Aug; 22(4):268-77. PubMed ID: 9669664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line.
    Wang XZ; Jolicoeur EM; Conte N; Chaffanet M; Zhang Y; Mozziconacci MJ; Feiner H; Birnbaum D; Pébusque MJ; Ron D
    Oncogene; 1999 Oct; 18(41):5718-21. PubMed ID: 10523851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.
    Paterson AL; Pole JC; Blood KA; Garcia MJ; Cooke SL; Teschendorff AE; Wang Y; Chin SF; Ylstra B; Caldas C; Edwards PA
    Genes Chromosomes Cancer; 2007 May; 46(5):427-39. PubMed ID: 17285574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
    Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
    Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
    Letessier A; Sircoulomb F; Ginestier C; Cervera N; Monville F; Gelsi-Boyer V; Esterni B; Geneix J; Finetti P; Zemmour C; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Chaffanet M
    BMC Cancer; 2006 Oct; 6():245. PubMed ID: 17040570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion and amplification of two originally non-syntenic chromosomal regions in a mammary carcinoma cell line.
    Lafage M; Pedeutour F; Marchetto S; Simonetti J; Prosperi MT; Gaudray P; Birnbaum D
    Genes Chromosomes Cancer; 1992 Jul; 5(1):40-9. PubMed ID: 1384661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation.
    Liu X; Baker E; Eyre HJ; Sutherland GR; Zhou M
    Oncogene; 1999 Nov; 18(50):7110-4. PubMed ID: 10597312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome translocations in breast cancer with breakpoints at 8p12.
    Courtay-Cahen C; Morris JS; Edwards PA
    Genomics; 2000 May; 66(1):15-25. PubMed ID: 10843800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
    Kwek SS; Roy R; Zhou H; Climent J; Martinez-Climent JA; Fridlyand J; Albertson DG
    Oncogene; 2009 Apr; 28(17):1892-903. PubMed ID: 19330026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation.
    Pole JC; Courtay-Cahen C; Garcia MJ; Blood KA; Cooke SL; Alsop AE; Tse DM; Caldas C; Edwards PA
    Oncogene; 2006 Sep; 25(41):5693-706. PubMed ID: 16636668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
    Adélaïde J; Huang HE; Murati A; Alsop AE; Orsetti B; Mozziconacci MJ; Popovici C; Ginestier C; Letessier A; Basset C; Courtay-Cahen C; Jacquemier J; Theillet C; Birnbaum D; Edwards PA; Chaffanet M
    Genes Chromosomes Cancer; 2003 Aug; 37(4):333-45. PubMed ID: 12800145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural heterogeneity of hsr(11) in the MDA-MB-134 mammary carcinoma cell line.
    Lemieux N; Apiou F; Vogt N; Malfoy B; Dutrillaux B
    Cancer Genet Cytogenet; 1996 Aug; 90(1):75-9. PubMed ID: 8780752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 11q13 amplicon of a mammary carcinoma cell line.
    Lafage M; Nguyen C; Szepetowski P; Pébusque MJ; Simonetti J; Courtois G; Gaudray P; deLapeyriere O; Jordan B; Birnbaum D
    Genes Chromosomes Cancer; 1990 Sep; 2(3):171-81. PubMed ID: 2078507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
    Holm K; Staaf J; Jönsson G; Vallon-Christersson J; Gunnarsson H; Arason A; Magnusson L; Barkardottir RB; Hegardt C; Ringnér M; Borg A
    Breast Cancer Res Treat; 2012 Jun; 133(2):583-94. PubMed ID: 22002566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.
    Lundgren K; Holm K; Nordenskjöld B; Borg A; Landberg G
    Breast Cancer Res; 2008; 10(5):R81. PubMed ID: 18823530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
    Prentice LM; Shadeo A; Lestou VS; Miller MA; deLeeuw RJ; Makretsov N; Turbin D; Brown LA; Macpherson N; Yorida E; Cheang MC; Bentley J; Chia S; Nielsen TO; Gilks CB; Lam W; Huntsman DG
    Oncogene; 2005 Nov; 24(49):7281-9. PubMed ID: 16027731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.
    Reis-Filho JS; Simpson PT; Turner NC; Lambros MB; Jones C; Mackay A; Grigoriadis A; Sarrio D; Savage K; Dexter T; Iravani M; Fenwick K; Weber B; Hardisson D; Schmitt FC; Palacios J; Lakhani SR; Ashworth A
    Clin Cancer Res; 2006 Nov; 12(22):6652-62. PubMed ID: 17121884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution array CGH clarifies events occurring on 8p in carcinogenesis.
    Cooke SL; Pole JC; Chin SF; Ellis IO; Caldas C; Edwards PA
    BMC Cancer; 2008 Oct; 8():288. PubMed ID: 18840272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.